Copper activates HIF-1α/GPER/VEGF signalling in cancer cells
- PMID: 26415222
- PMCID: PMC4741443
- DOI: 10.18632/oncotarget.5779
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells
Abstract
Copper promotes tumor angiogenesis, nevertheless the mechanisms involved remain to be fully understood. We have recently demonstrated that the G-protein estrogen receptor (GPER) cooperates with hypoxia inducible factor-1α (HIF-1α) toward the regulation of the pro-angiogenic factor VEGF. Here, we show that copper sulfate (CuSO4) induces the expression of HIF-1α as well as GPER and VEGF in breast and hepatic cancer cells through the activation of the EGFR/ERK/c-fos transduction pathway. Worthy, the copper chelating agent TEPA and the ROS scavenger NAC prevented the aforementioned stimulatory effects. We also ascertained that HIF-1α and GPER are required for the transcriptional activation of VEGF induced by CuSO4. In addition, in human endothelial cells, the conditioned medium from breast cancer cells treated with CuSO4 promoted cell migration and tube formation through HIF-1α and GPER. The present results provide novel insights into the molecular mechanisms involved by copper in triggering angiogenesis and tumor progression. Our data broaden the therapeutic potential of copper chelating agents against tumor angiogenesis and progression.
Keywords: GPER; HIF-1α; Pathology Section; VEGF; angiogenesis; cancer; copper.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g006.gif)
![formula image](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-i013.jpg)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g007.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g008.gif)
![Figure 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g009.gif)
![Figure 10](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g010.gif)
![Figure 11](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g011.gif)
![Figure 12](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/4741443/bin/oncotarget-06-34158-g012.gif)
Similar articles
-
A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update.Int J Mol Sci. 2024 Mar 14;25(6):3313. doi: 10.3390/ijms25063313. Int J Mol Sci. 2024. PMID: 38542288 Free PMC article. Review.
-
Crosstalk between Notch, HIF-1α and GPER in Breast Cancer EMT.Int J Mol Sci. 2018 Jul 10;19(7):2011. doi: 10.3390/ijms19072011. Int J Mol Sci. 2018. PMID: 29996493 Free PMC article. Review.
-
GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.Breast Cancer Res. 2017 Dec 6;19(1):129. doi: 10.1186/s13058-017-0923-5. Breast Cancer Res. 2017. PMID: 29212519 Free PMC article.
-
Estrogen stabilizes hypoxia-inducible factor 1α through G protein-coupled estrogen receptor 1 in eutopic endometrium of endometriosis.Fertil Steril. 2017 Feb;107(2):439-447. doi: 10.1016/j.fertnstert.2016.11.008. Epub 2016 Dec 8. Fertil Steril. 2017. PMID: 27939762 Free PMC article.
-
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs).Breast Cancer Res. 2013;15(4):R64. doi: 10.1186/bcr3458. Breast Cancer Res. 2013. PMID: 23947803 Free PMC article.
Cited by
-
Copper in colorectal cancer: From copper-related mechanisms to clinical cancer therapies.Clin Transl Med. 2024 Jun;14(6):e1724. doi: 10.1002/ctm2.1724. Clin Transl Med. 2024. PMID: 38804588 Free PMC article. Review.
-
Targeting cuproplasia and cuproptosis in cancer.Nat Rev Clin Oncol. 2024 May;21(5):370-388. doi: 10.1038/s41571-024-00876-0. Epub 2024 Mar 14. Nat Rev Clin Oncol. 2024. PMID: 38486054 Review.
-
The Antitumor Impact of Combining Hepatic Artery Ligation With Copper Chelators for Liver Cancer.Clin Med Insights Oncol. 2023 Nov 22;17:11795549231204612. doi: 10.1177/11795549231204612. eCollection 2023. Clin Med Insights Oncol. 2023. PMID: 38023286 Free PMC article.
-
Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies.Front Pharmacol. 2023 Sep 12;14:1271613. doi: 10.3389/fphar.2023.1271613. eCollection 2023. Front Pharmacol. 2023. PMID: 37767404 Free PMC article. Review.
-
Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson's Phenotype Development.Antioxidants (Basel). 2023 Aug 22;12(9):1654. doi: 10.3390/antiox12091654. Antioxidants (Basel). 2023. PMID: 37759957 Free PMC article. Review.
References
-
- Kim BE, Nevitt T, Thiele DJ. Mechanisms for copper acquisition, distribution and regulation. Nat ChemBiol. 2008;3:176–185. - PubMed
-
- Georgopoulos PG, Roy A, Yonone-Lioy MJ, Opiekun RE, Lioy PJ. Environmental copper: its dynamics and human exposure issues. J Toxicol Environ Health B Crit Rev. 2001;4:341–394. - PubMed
-
- Agency for Toxic Substances and Disease Registry. Atlanta, GA: US Public Health Service; 1990. Toxicological Profile for Copper; p. p43.
-
- Rocha GH, Lini RS, Barbosa F Jr. Batista BL, de Oliveira Souza VC, Nerilo SB, Bando E, Mossini SA, Nishiyama P. Exposure to heavy metals due to pesticide use by vineyard farmers. Int Arch Occup Environ Health. 2015;88:875–80. - PubMed
-
- Antoniades V, Sioga A, Dietrich EM, Meditskou S, Ekonomou L, Antoniades K. Is copper chelation an effective anti-angiogenic strategy for cancer treatment? Med Hypotheses. 2013;6:1159–1163. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous